US Bancorp’s Vyant Bio VYNT Stock Holding History
Bought
Maintained
Sold
Other funds holding VYNT
US Bancorp's VYNT Position: Q2 2023 in Review
US Bancorp sold out of Vyant Bio (VYNT) in Q2 2023, closing a stake of 4,962 shares — an estimated $2.88K sold.
US Bancorp first reported a position in VYNT in Q3 2016 and held it in 10 quarters. The position peaked at $35K in Q1 2022. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.
- US Bancorp reported no remaining Vyant Bio position as of Q2 2023 after selling out during the quarter.
- US Bancorp sold 4,962 Vyant Bio shares in Q2 2023, an estimated $2.88K.
- US Bancorp first reported a position in Vyant Bio in Q3 2016 and held it in 10 quarters.
- US Bancorp's Vyant Bio position peaked at $35K in Q1 2022.
- 1 fund tracked by Wall St. Rank held Vyant Bio as of Q2 2023.
Based on US Bancorp's 13F filing for Q2 2023, filed 10 Aug 2023.